Did you mean: Grover v. Bristol-Myers Squibb Company et al?
Web Results

Bristol-Myers Escapes $3.4B Apotex Suit Over Plavix Deal - Law360


Mar 14, 2013 ... Bristol-Myers Squibb Co. and partner Sanofi-Aventis SA won a defense verdict Wednesday in a $3.4 billion ... The case is Apotex Inc. et al. v.

New Drugs and Novel Mechanisms of Action in Multiple Myeloma in ...


Nov 20, 2013 ... Regarding the optimal dose and schedule of administration (2 vs. ..... to the minor groove of DNA and induces DNA double-strand breaks. ..... Conflicts of interest: EMO: Consultancy: Onyx; Bristol Myers Squibb; Array Pharmaceuticals. .... Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, et al.

Envelope Conformational Changes Induced by Human ... - NCBI


BMS-488043 is compound 5ao in a patent by T. Wang et al. ... from the University of Massachusetts or were prepared at Bristol-Myers Squibb Company. ..... Inhibition of virion (WT versus ΔCT)-sCD4 binding by attachment inhibitors ... CD4-induced exposure of the virion N-terminal heptad repeat groove was probed by C34 ...

Patent Docs: Court Report - Patentdocs.org


Apr 3, 2014 ... Bristol-Myers Squibb Company v. Apotex Inc. et al. 1:14-cv-00351; filed March 19 , 2014 in the District Court of Delaware • Plaintiff: Bristol-Myers ...

In Vivo Characterization of the Mitochondrial Selective KATP Opener ...


Apr 17, 2002 ... Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Pennington, ... 1993; Grover et al., 1995a; Chutkow et al., 1996; Inagaki et ... openers such as BMS-180448 and BMS- 191095 (Atwal et al., ...... APD shortening effects versus cardioprotection (Atwal et al.

Cell Research - Structural basis for blocking PD-1-mediated immune ...


Jun 21, 2016 ... One is nivolumab or Opdivo from Bristol-Myers Squibb. ... that the C′D loop of hPD-1 protrudes into a groove formed by the CDRs and FR of pembrolizumab Fab. .... Article | PubMed |; Cheng X, Veverka V, Radhakrishnan A, et al. ... 07 August 2016 — 12 August 2016; 110 Carriage Way, CO, United States.

False Claims Cases Filed January 1, 2007 – June 30, 2013 - Navigant

www.navigant.com/~/media/WWW/Site/Insights/Disputes Investigations/FCA_Quarterly Report Tracker for pdf_Sept 2013.pdf

Jun 28, 2013 ... Crawley V. Harrisburg Area Community College Et Al. Todd A. Crawley. Frank P. ...... Robert A. Grover, DO; Robert. A. Grover, DO, PA .... United States Of America Et Al V. Bristol Myers Squibb Company Et Al. United States of ...

Get PDF (154K) - Wiley Online Library


Louis Rosenfeld,1 Gary J. Grover,2 and Charles T. Stier, Jr.1. 1Department of ... 2Division of Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb, .... From the analogs prepared, BMS-180,291: [(+)-1S-(1a,2a,3a, ... scopic analysis was developed by Jemal et al. ..... by combination with aspirin (12 ± 2 vs.

Role of Myocardial ATP-Sensitive Potassium Channels ... - Circulation


From the Department of Pharmacology, Bristol-Myers Squibb. Pharmaceutical ... Grover et al KATP and Al-Receptors in Preconditioning. 1311 artery for ... min glyburide (Sigma Chemical Co., St. Louis, Mo.) .... V * 51.94 3.61x R . 0.30 a cc u. N.

Cardioprotective Effect of Diazoxide and Its Interaction With ...


113 Results ... Rat heart mitochondria were prepared according to Matlib et al<sup>17</sup> and inner .... was synthesized in the Department of Chemistry at Bristol-Myers Squibb. All other compounds were obtained from Sigma Chemical Co. ..... Relative K<sup>+</sup> flux, ( ΔJ/ΔJmax) is plotted vs concentration of drug added to the assay.

More Info

Judge Sleet | Delaware Intellectual Property Litigation


By Memorandum Order entered by The Honorable Gregory M. Sleet in Bristol- Myers Squibb Co., et al. v. Merck & Co., Inc., et al., Civil Action No. 15-560-GMS ...

Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as ...


Feb 26, 2004 ... (1)Department of Chemistry, The Bristol-Myers Squibb Pharmaceutical ... for the F1F0 mitochondrial ATP hydrolase vs mitochondrial KATP.

Impairment of Type I but Not Type III IFN Signaling by Hepatitis C ...


Mar 31, 2015 ... Conversely, the type III IFN co-receptor subunit IL28RA was not affected in this model, .... In agreement with these findings, Chandra et al. recently showed in an .... All authors of this manuscript are employees of Bristol-Myers Squibb. .... Francois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, ...